Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BiomeNrich POST M005 Becomes First Akkermansia Muciniphila Ingredient to Receive NDIN Notification - Nutraceuticals World

What are you searching for?

Sign in
Market Updates, Products & Ingredients

BiomeNrich POST M005 Becomes First Akkermansia Muciniphila Ingredient to Receive NDIN Notification

The postbiotic was associated with measures of muscle health in a clinical study.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Rolling Stones | Adobe Stock

Ingredient supplier CJ BIO’s Akkermansia muciniphila postbiotic ingredient became the first strain of its species to receive a New Dietary Ingredient Notification acknowledgement from the U.S. Food and Drug Administration (FDA), the company reported.

Strains of Akkermansia muciniphila have been evidenced to support gut and metabolic health, but none have received acknowledgment from FDA through the NDIN process, instead going through the self-affirmed GRAS process.

BiomeNrich POST M005 is a postbiotic comprised of heat-killed microbes, offering enhanced stability, safety, and efficacy over traditional probiotics.

In a randomized, double-blind, placebo-controlled clinical trial with 92 participants, patients in the treatment group experienced improved measures in muscle strength and function over 12 weeks. Compared to placebo, the treatment group saw a 200% increase in leg strength and a 130% increase in follistatin, a muscle-supporting protein.

“We are pleased to contribute to the growth of the nutrition industry, especially in the areas of muscle health and healthy aging,” CJ BIO stated. “With the completion of NDI, we believe this milestone will create more opportunities for CPG brands to deliver unique and innovative products to the market using BiomeNrich POST M005.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics